The long noncoding RNA linc00858 promotes progress of lung cancer through miR-3182/MMP2 axis

References

• 1. Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet. 2000;355:479–485.
   PubMed Web of Science ®Google Scholar
• 2. Liu Q, Huang J, Zhou N, et al. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res. 2013;41:4976–4987.
   PubMed Web of Science ®Google Scholar
• 3. Jia Y, Ying X, Zhou J, et al. The novel KLF4/PLAC8 signaling pathway regulates lung cancer growth. Cell Death Dis. 2018;9:603.
   PubMed Web of Science ®Google Scholar
• 4. Castell A, Larsson LG. Targeting MYC translation in colorectal cancer. Cancer Discov. 2015;5:701–703.
   PubMed Web of Science ®Google Scholar
• 5. Gu J, Wang Y, Wang X, et al. Downregulation of lncRNA GAS5 confers tamoxifen resistance by activating miR-222 in breast cancer. Cancer Lett. 2018;434:1–10.
   PubMed Web of Science ®Google Scholar
• 6. Hannen R, Bartsch JW. Essential roles of telomerase reverse transcriptase hTERT in cancer stemness and metastasis. FEBS Lett. 2018;592:2023–2031.
   PubMed Web of Science ®Google Scholar
• 7. Lin C, Yang L. Long noncoding RNA in cancer: wiring signaling circuitry. Trends Cell Biol. 2017. 28:287–301.
   PubMed Web of Science ®Google Scholar
• 8. Chen Z, Li JL, Lin S, et al. cAMP/CREB-regulated LINC00473 marks LKB1-inactivated lung cancer and mediates tumor growth. J Clin Invest. 2016;126:2267–2279.
   PubMed Web of Science ®Google Scholar
• 9. Jan S, Laba TL, Essue BM, et al. Action to address the household economic burden of non-communicable diseases. Lancet. 2018;391:2047–2058.
   PubMed Web of Science ®Google Scholar
• 10. Lu Z, Li Y, Che Y, et al. The TGFβ-induced lncRNA TBILA promotes non-small cell lung cancer progression in vitro and in vivo via cis-regulating HGAL and activating S100A7/JAB1 signaling. Cancer Lett. 2018;432:156–168.
   PubMed Web of Science ®Google Scholar
• 11. Arab K, Park YJ, Lindroth AM, et al. Long noncoding RNA TARID directs demethylation and activation of the tumor suppressor TCF21 via GADD45A. Mol Cell. 2014;55:604–614.
   PubMed Web of Science ®Google Scholar
• 12. Scheuermann JC, Boyer LA. Getting to the heart of the matter: long non-coding RNAs in cardiac development and disease. Embo J. 2013;32:1805–1816.
   PubMed Web of Science ®Google Scholar
• 13. Milagro FI, Mansego ML, De Miguel C, et al. Dietary factors, epigenetic modifications and obesity outcomes: progresses and perspectives. Mol Aspects Med. 2013;34:782–812.
   PubMed Web of Science ®Google Scholar
• 14. Wyld L, Audisio RA, Poston GJ. The evolution of cancer surgery and future perspectives. Nat Rev Clin Oncol. 2015;12:115–124.
   PubMed Web of Science ®Google Scholar
• 15. Doubeni CA, Gabler NB, Wheeler CM, et al. Timely follow-up of positive cancer screening results: a systematic review and recommendations from the PROSPR Consortium. CA Cancer J Clin. 2018; 68:199–216.
   PubMed Web of Science ®Google Scholar
• 16. Song YX, Sun JX, Zhao JH, et al. Non-coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion. Nat Commun. 2017;8:289.
   PubMed Web of Science ®Google Scholar
• 17. Xie X, Zhang Y, Li F, et al. Challenges and opportunities from basic cancer biology for nanomedicine for targeted drug delivery. Curr Cancer Drug Targets. 2019;19:257–276.
   PubMed Web of Science ®Google Scholar
• 18. Yuan X, Wu H, Han N, et al. Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application. J Hematol Oncol. 2014;7:87.
   PubMed Web of Science ®Google Scholar
• 19. Dubois F, Keller M, Calvayrac O, et al. RASSF1A suppresses the invasion and metastatic potential of human non-small cell lung cancer cells by inhibiting YAP activation through the GEF-H1/RhoB pathway. Cancer Res. 2016;76:1627–1640.
   PubMed Web of Science ®Google Scholar
• 20. Li Y, Zhang H, Li Y, et al. MiR‐182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene. Mol Carcinog. 2018;57:125–136.
   PubMed Web of Science ®Google Scholar
• 21. Zhang X, Sai B, Wang F, et al. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT. Mol Cancer. 2019;18:40.
   PubMed Web of Science ®Google Scholar
• 22. Pan Q, Meng L, Ye J, et al. Transcriptional repression of miR-200 family members by Nanog in colon cancer cells induces epithelial-mesenchymal transition (EMT). Cancer Lett. 2017;392:26–38.
   PubMed Web of Science ®Google Scholar
• 23. Dong M, Wang X, Zhao HL, et al. Integrated analysis of transcription factor, microRNA and LncRNA in an animal model of obliterative bronchiolitis. Int J Clin Exp Pathol. 2015;8:7050–7058.
   PubMed Web of Science ®Google Scholar
• 24. Zhu KP, Ma XL, Zhang CL. LncRNA ODRUL contributes to osteosarcoma progression through the miR-3182/MMP2 axis. Mol Ther. 2017;25:2383–2393.
   PubMed Web of Science ®Google Scholar
• 25. Ju L, Han M, Li X, et al. MicroRNA signature of lung adenocarcinoma with EGFR exon 19 deletion. J Cancer. 2017;8:1311–1318.
   PubMed Web of Science ®Google Scholar
• 26. Razaviyan J, Hadavi R, Tavakoli R, et al. Expression of miRNAs targeting mTOR and S6K1 genes of mTOR signaling pathway including miR-96, miR-557, and miR-3182 in triple-negative breast cancer. Appl Biochem Biotechnol. 2018;186:1074–1089.
   PubMed Web of Science ®Google Scholar